Company profile for Emerald Health Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Emerald Health Pharmaceuticals (EHP), we are focused on the development of a new class of drugs with precise mechanisms of action aimed at bringing innovative therapies to patients to treat diseases with significant unmet medical needs. We believe our novel patented molecules have the potential to be developed into safe and effective pharmaceutical compounds to treat a wide range of diseases, such as neurodegenerative, a...
At Emerald Health Pharmaceuticals (EHP), we are focused on the development of a new class of drugs with precise mechanisms of action aimed at bringing innovative therapies to patients to treat diseases with significant unmet medical needs. We believe our novel patented molecules have the potential to be developed into safe and effective pharmaceutical compounds to treat a wide range of diseases, such as neurodegenerative, auto-immune, inflammatory, fibrotic, cardiovascular, and metabolic diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5910 Pacific Center Blvd., #300 San Diego, CA, 92121
Telephone
Telephone
1.858.352.0622
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2021/12/02/2345389/0/en/Emerald-Health-Pharmaceuticals-Novel-Drug-Candidate-Demonstrates-Significant-Anti-inflammatory-and-Anti-fibrotic-Activity-in-Multi-organ-Fibrosis-Preclinical-Model.html

GLOBENEWSWIRE
02 Dec 2021

https://www.globenewswire.com/news-release/2020/03/03/1994306/0/en/Emerald-Health-Pharmaceuticals-Receives-Fast-Track-Designation-from-US-FDA-for-EHP-101-in-the-Treatment-of-Systemic-Sclerosis.html

GLOBENEWSWIRE
03 Mar 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty